IMBiologics Corp. (KOSDAQ:493280)
South Korea · Delayed Price · Currency is KRW 26,900
+350 (1.32%)
At close: Jun 11, 2026
IMBiologics Market Cap
IMBiologics has a market cap or net worth of 413.77 billion as of June 12, 2026.
Market Cap
413.77B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
26,900.00
Market Cap Chart
Since March 20, 2026, IMBiologics's market cap has decreased from 1.54T to 413.77B, a decrease of -73.07%. That is a compound annual growth rate of -99.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 413.77B | 3.90% |
| Jun 11, 2026 | 398.23B | 1.32% |
| Jun 10, 2026 | 393.05B | 1.53% |
| Jun 9, 2026 | 387.13B | 7.61% |
| Jun 8, 2026 | 359.74B | -12.59% |
| Jun 5, 2026 | 411.55B | -7.33% |
| Jun 4, 2026 | 444.12B | 4.53% |
| Jun 2, 2026 | 424.88B | -6.36% |
| Jun 1, 2026 | 453.74B | -5.26% |
| May 29, 2026 | 478.91B | -8.49% |
| May 28, 2026 | 523.32B | -3.81% |
| May 27, 2026 | 544.05B | -4.17% |
| May 26, 2026 | 567.74B | 1.05% |
| May 22, 2026 | 561.81B | 5.42% |
| May 21, 2026 | 532.95B | 1.84% |
| May 20, 2026 | 523.32B | -6.48% |
| May 19, 2026 | 559.59B | -1.56% |
| May 18, 2026 | 568.48B | -6.34% |
| May 15, 2026 | 606.97B | -7.34% |
| May 14, 2026 | 655.08B | 20.90% |
| May 13, 2026 | 541.83B | -6.51% |
| May 12, 2026 | 579.58B | 0.64% |
| May 11, 2026 | 575.88B | -9.95% |
| May 8, 2026 | 639.53B | -1.93% |
| May 7, 2026 | 652.12B | -2.44% |
| May 6, 2026 | 668.40B | -2.90% |
| May 4, 2026 | 688.39B | -4.32% |
| Apr 30, 2026 | 719.48B | -4.52% |
| Apr 29, 2026 | 753.53B | -5.21% |
| Apr 28, 2026 | 794.98B | -3.59% |
| Apr 27, 2026 | 824.59B | 3.92% |
| Apr 24, 2026 | 793.50B | 3.08% |
| Apr 23, 2026 | 769.81B | 1.17% |
| Apr 22, 2026 | 760.93B | -6.72% |
| Apr 21, 2026 | 815.70B | -9.94% |
| Apr 20, 2026 | 905.78B | 5.33% |
| Apr 17, 2026 | 859.97B | -4.90% |
| Apr 16, 2026 | 904.30B | -0.49% |
| Apr 15, 2026 | 908.73B | 0.99% |
| Apr 14, 2026 | 899.87B | 7.98% |
| Apr 13, 2026 | 833.37B | 14.87% |
| Apr 10, 2026 | 725.51B | 3.48% |
| Apr 9, 2026 | 701.13B | -6.04% |
| Apr 8, 2026 | 746.19B | 15.83% |
| Apr 7, 2026 | 644.24B | -5.93% |
| Apr 6, 2026 | 684.87B | -1.07% |
| Apr 3, 2026 | 692.26B | -4.49% |
| Apr 2, 2026 | 724.77B | -14.99% |
| Apr 1, 2026 | 852.58B | 4.34% |
| Mar 31, 2026 | 817.12B | -15.83% |
| Mar 30, 2026 | 970.79B | -12.28% |
| Mar 27, 2026 | 1.11T | -3.10% |
| Mar 26, 2026 | 1.14T | 7.06% |
| Mar 25, 2026 | 1.07T | -2.43% |
| Mar 24, 2026 | 1.09T | -2.76% |
| Mar 23, 2026 | 1.12T | -26.83% |
| Mar 20, 2026 | 1.54T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 582.21B |
| Curocell | 430.13B |
| S.Biomedics | 380.84B |
| IntoCell | 356.02B |
| HansBiomed | 336.57B |
| Genome & Company | 259.75B |
| Kanaph Therapeutics | 249.42B |
| curacle co.,ltd. | 240.10B |